Baader Bank Aktiengesellschaft Sells 4,281 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Baader Bank Aktiengesellschaft reduced its holdings in UnitedHealth Group by 71.8%, selling 4,281 shares to own 1,685 shares worth approximately $526,000 as of its latest SEC filing.
• Analysts have mixed sentiments about UnitedHealth Group, with Oppenheimer lowering its price target from $400 to $325, while Morgan Stanley raised it from $325 to $395, indicating varying expectations for the stock's performance.
• The company recently announced a quarterly dividend of $2.21 per share, representing an annualized yield of 2.6%, with a dividend payout ratio of 38.30%.

Baader Bank Aktiengesellschaft trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 71.8% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 1,685 shares of the healthcare conglomerate's stock after selling 4,281 shares during the period. Baader Bank Aktiengesellschaft's holdings in UnitedHealth Group were worth $526,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Two Sigma Advisers LP bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $14,063,000. First Heartland Consultants Inc. increased its position in shares of UnitedHealth Group by 6.3% during the fourth quarter. First Heartland Consultants Inc. now owns 1,240 shares of the healthcare conglomerate's stock worth $627,000 after acquiring an additional 74 shares in the last quarter. Finally, Novem Group bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $854,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Finally, Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Trading Up 0.6%

Shares of NYSE:UNH traded up $1.90 during trading on Friday, reaching $336.72. The stock had a trading volume of 13,528,738 shares, compared to its average volume of 13,748,202. The firm's fifty day moving average is $295.67 and its 200 day moving average is $365.19. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market cap of $304.96 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 2.19 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.